Acute Ischaemic Stroke in Patients Treated with Direct Oral Anticoagulants: Potential Causes, Clinical Characteristics, and Short-Term Outcomes

Acute Ischaemic Stroke in Patients Treated with Direct Oral Anticoagulants: Potential Causes, Clinical Characteristics, and Short-Term Outcomes

Introduction. Direct oral anticoagulants (DOAC) are the first-line treatment for primary and secondary acute ischaemic stroke (AIS) prevention in patients with nonvalvular atrial fibrillation (NVAF), but a significant percentage of patients develop AIS despite being treated with DOAC. As the number...

Full description

Saved in:
Bibliographic Details
Main Authors: Katarzyna Sawczyńska, Ewa Włodarczyk, Aleksandra Pawlicka, Bartosz Kołodziejczyk, Paweł Wrona, Kamil Wężyk, Tomasz Homa, Paulina Sarba, Dominik Wróbel, Kaja Zdrojewska, Maria Sobolewska, Dawid Rolkiewicz, Agnieszka Slowik
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Stroke Research and Treatment
Online Access:http://dx.doi.org/10.1155/2024/2285722
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items